Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 25/10/30

Trade details

Type
Insider sale
Amount
$823,437.78
Shares · price
1,991 sh · $413.58 a share
Held after
2,139 sh
Trade date
25/10/28
Filed
25/10/30
Days to filing
2 days

Sold 48.2% of holdings

Share of holding sold
48.2%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/28~25/11/27

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1.1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $664.2K

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $574.9K

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $262.3K

    Filed 09/30

Martine A. Rothblatt, Chairman — sold $823.4K of United Therapeutics UTHR · 48.2% of holdings · 10b5-1 plan | Whalegun